Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

mehr ...

erschienen in

mehr ...

Verlag

mehr ...

Sprache

Datenbank

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 22 von 22, Suchdauer: 0.54s

1
Patient- and family-centered performance measures focused on actionable processes of care for persistent and chronic critical illness: protocol for a systematic review

von Louise Rose ; Laura Istanboulian ; Laura Allum ; et al.

Systematic Reviews, Vol 6, Iss 1, Pp 1-6 (2017)

Schlagworte: Chronic critical illness; Persistent critical illness; Quality indicator; Process of care; Intensive care; Medicine
- View full text via DOI
Merkliste

2
Patient and Family Centered Actionable Processes of Care and Performance Measures for Persistent and Chronic Critical Illness: A Systematic Review

von Louise Rose, PhD ; Laura Istanboulian, MN ; Laura Allum, MSc ; et al.

Critical Care Explorations, Vol 1, Iss 4, p e0005 (2019)

Schlagworte: Medical emergencies. Critical care. Intensive care. First aid; RC86-88.9
- View full text via DOI
Merkliste

3
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- Zur Referenz in Web of Science
Merkliste

4
Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial

von Bousser MG ; Amarenco P ; Chamorro A ; et al.
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

5
Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial

von Marie Germaine Bousser ; Pierre Amarenco ; Angel Chamorro ; et al.

Schlagworte: stroke; trial multicentrico; aspirina
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

6
Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (perform) study

von BOUSSER MG ; AMARENCO P ; CHAMORRO A ; et al.

Schlagworte: antiplatelet therapy; aspirin; DementiaI; schemic; stroke; perform study; transient ischemic attack; terutroban; tp receptor antagonist; stroke prevention
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

7
THE PREVENTION OF CEREBROVASCULAR AND CARDIOVASCULAR EVENT OF ISCHEMIC ORIGIN WITH TERUTROBAN IN PATIENTS WITH HISTOTY OF ISCHEMIC STROKE OR TRANSIENT ISCHEMIC ATTACK (PERFORM) STUDY: BASELINE CHARACTERISTIC OF THE POPULATION

von M. G. BOUSSER ; P. AMARENCO ; A. CHAMORRO ; et al.
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

8
Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or .

von BOUSSER M ; AMARENCO P ; CHAMORRO A ; et al.
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

9
Rationale and Design of a randomized,Double-Blind.Parallel-Group Study of Terutroban 30mg day versus Aspirin 100 mg.day in Stroke Patients:The Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attak(Perform)Study

von BOUSSER M. G ; AMARENCO P ; CHAMORRO A ; et al.
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

10
The Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack(PERFORM) Study:Baseline Characteristics of the Population

von BOUSSER M. G ; AMARENCO P ; CHAMORRO A ; et al.
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

11
Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: The prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study

von Bousser, M ; Amarenco, P ; Chamorro, A ; et al.

Schlagworte: Treatment Outcome; Aged, 80 and over; Male; Propionic Acid; Platelet Aggregation Inhibitor; Middle Aged; Female; Dose-Response Relationship, Drug; Double-Blind Method; Cardiovascular Disease; Human; Receptors, Thromboxane; Ischemic Attack, Transient; Naphthalene; Aged; Aspirin; Stroke; Endpoint Determination; International Cooperation; info:eu-repo/semantics/article
- Zum Volltext über OAIster
Merkliste

12
Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial

von Bousser, Marie-Germaine ; Amarenco, Pierre ; Chamorro, Angel ; et al.

Bousser, Marie-Germaine; Amarenco, Pierre; Chamorro, Angel; Fisher, Marc; Ford, Ian; Fox, Kim M; Hennerici, Michael G; Mattle, Heinrich P; Rothwell, Peter M; de Cordoüe, Agnès; Fratacci, Marie-Dominique; PERFORM Study Investigators, (2011). Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial. Lancet, 377(9782), pp. 2013-22. London: Elsevier 10.1016/S0140-6736(11)60600-4
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

13
Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial.

von Bousser, MG ; Amarenco, P ; Chamorro, A ; et al.

Schlagworte: info:eu-repo/classification/ddc
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

14
Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.

von Bousser, MG ; Amarenco, Pierre ; Chamorro, A ; et al.

Cerebrovascular diseases, 27 (5

Schlagworte: Sciences bio-médicales et agricoles; Aged; 80 and over; Aspirin -- adverse effects; Aspirin -- therapeutic use; Cardiovascular Diseases -- etiology; Cardiovascular Diseases -- prevention & control; Dose-Response Relationship; Drug; Double-Blind Method; Endpoint Determination; Female; Humans; International Cooperation; Ischemic Attack; Transient -- complications; Transient -- drug therapy; Male; Middle Aged; Naphthalenes -- adverse effects; Naphthalenes -- therapeutic use; Platelet Aggregation Inhibitors -- adverse effects; Platelet Aggregation Inhibitors -- therapeutic use; Propionic Acids -- adverse effects; Propionic Acids -- therapeutic use; Receptors; Thromboxane -- antagonists & inhibitors; Stroke -- complications; Stroke -- drug therapy; Stroke -- etiology
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

15
The prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study: Baseline characteristics of the population

von Bousser, M ; Amarenco, P ; Chamorro, A ; et al.

Schlagworte: Recurrence; Male; Propionic Acid; Platelet Aggregation Inhibitor; Middle Aged; Female; Risk Factor; Dose-Response Relationship, Drug; Double-Blind Method; Human; Receptors, Thromboxane; Diabetes Complication; Ischemic Attack, Transient; Naphthalene; Activities of Daily Living; Aged; Aspirin; Hypertension; Severity of Illness Index; Cognition; Stroke; International Cooperation; info:eu-repo/semantics/article
- Zum Volltext über OAIster
Merkliste

16
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- Zur Referenz in Web of Science
Merkliste

17
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- Zur Referenz in Web of Science
Merkliste

18
Patient and Family Centered Actionable Processes of Care and Performance Measures for Persistent and Chronic Critical Illness: A Systematic Review

von Rose, Louise ; Istanboulian, Laura ; Allum, laura ; et al.
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

19
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- Zur Referenz in Web of Science
Merkliste

20
Patient- and family-centered performance measures focused on actionable processes of care for persistent and chronic critical illness : protocol for a systematic review

von Rose, Louise ; Istanboulian, Laura ; Allum, Laura ; et al.

Schlagworte: chronic critical illness; persistent critical illness; quality indicator; process of care; intensive care
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

21
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- Zur Referenz in Web of Science
Merkliste

22
Twenty patients including 7 probands with autosomal dominant cutis laxa confirm clinical and molecular homogeneity.

von Hadj-Rabia, Smail ; Callewaert, Bert ; Bourrat, Emmanuelle ; et al.

ISSN: 1750-1172 ; Orphanet Journal of Rare Diseases ; https://inserm.hal.science/inserm-00798332 ; Orphanet Journal of Rare Diseases, 2013, 8 (1), pp.36. ⟨10.1186/1750-1172-8-36⟩.

Schlagworte: Elastin; ELN; Autosomal dominant cutis laxa; Genotype; Phenotype; [SDV.GEN]Life Sciences [q-bio]/Genetics
- View full text via BASE
Merkliste

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag